Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Medisca

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “We’re investing in next-gen CDMO & peptide building blocks infrastructure to support the evolving demands of complex therapies.”

    mic“We’re investing in next-gen CDMO & peptide building blocks infrastructure to support the evolving demands of complex therapies.”

    This week, SpeakPharma interviews Dr. Abdelaziz Toumi, Chief Executive Officer of Lupin Manufacturing Solutions (LMS). In this exclusive interview with PharmaCompass, Dr. Toumi discusses the evolving CDMO landscape, the shift toward complex therapies and growing peptide ecosystems along with LMS’s recent strategic investments in integrated CDMO and peptide building blocks infrastructure. As the industry convenes at DCAT Week, he highlights how LMS is positioning itself as a capability-driven CDMO partner for next-gen complex therapies.Dr. Toumi, The US has been taking several steps to reduce dependence on overseas pharmaceutical supply chains. How is Lupin Manufacturing Solutions (LMS) navigating these shifts?The framing of this debate as globalization versus reshoring misses what is actually happening. What we are seeing is a deliberate recalibration, a move from networks built purely for cost efficiency toward architectures that distribute risk more intelligently. That is a fundamentally different objective, and it changes what pharmaceutical companies expect from their manufacturing partners. What policymakers are pushing for, whether through the BIOSECURE Act or broader reshoring incentives, is a strategic allocation of manufacturing risk, and that is entirely rational.For LMS, this environment plays to our strengths. We have never positioned ourselves as a low-cost volume provider. Our competitive case is built on technical capability, regulatory reliability, and the ability to manage genuinely complex chemistry programs. Those attributes matter most to customers re-evaluating their supply relationships. Our investments in HPAPI containment, peptide building blocks, and integrated CDMO infrastructure reflect a deliberate commitment to being relevant precisely where complexity is highest. That is where we see sustained and growing demand, irrespective of how supply chain policy continues to evolve.How do you see the pharmaceutical landscape evolving over the next five years? How is LMS positioning itself to stay ahead of these changes?Five years from now, the defining feature of this industry will be the sheer scientific complexity embedded in pharmaceutical pipelines. Peptides, targeted oncology compounds, radiopharmaceuticals, these are not molecules you manufacture through conventional means. They demand deep process chemistry, specialized infrastructure, and partners who can genuinely co-develop solutions rather than simply execute a manufacturing order.That shift is changing how innovation-driven companies select their CDMO partners. Technical depth, regulatory track record, and the ability to navigate development risk have moved to the top of the evaluation criteria. At LMS, everything we are building right from our integrated CDMO block at Dabhasa to our HPAPI infrastructure at Vizag is calibrated to this reality. We are positioning to be a partner of choice and not just a transactional service provider.Could you provide an update on LMS’ oncology (HPAPI) manufacturing block in Visakhapatnam? How is it contributing to your CDMO strategy?Oncology manufacturing is one of the most technically exciting segments in the industry, and that complexity is only intensifying. As targeted therapies and antibody drug conjugates advance through pipelines, the demand for high-potency API capability delivered reliably, at global safety standards continues to grow.Our Vizag facility has been designed with that reality in mind, and that goes beyond containment engineering. It incorporates the process discipline, safety culture, and quality systems that high-potency manufacturing demands at every level of the organization. You cannot retrofit this kind of capability; it has to be purpose-built. What we have put in place is a platform that supports programs from early clinical development through commercial supply offering customers the continuity they need without transferring between sites as their programs mature. That continuity is a genuine competitive advantage.In December, LMS signed a strategic alliance with PolyPeptide Group AG to scale the global peptide supply chain. How will this collaboration strengthen your CDMO capabilities in the fast-growing peptide therapeutics segment?The rapid growth of peptide therapeutics, especially GLP1s, has fundamentally changed how the industry thinks about scale, reliability, and supply security. What was once a niche capability has become a core requirement, and customers are now looking for partners who can support the peptide value chain end-to-end, at a global scale.LMS’s strategy is built around serving the entire peptide market and establishing a globally competitive platform over the next three to five years, rooted in India, positioning itself as a credible partner amidst the China+1 strategy, capable of supporting both innovators and large pharmaceutical companies. The strategic alliance with PolyPeptide Group fits naturally within this vision allowing us to complement our own capabilities with additional synthesis depth and geographic flexibility, particularly for customers seeking resilient, diversified supply chains.LMS brings deep process chemistry expertise, a growing peptide intermediates and building blocks platform at Dabhasa, and strong regulatory execution. Importantly, as part of the Lupin group, we are also able to offer downstream drug product manufacturing capabilities spanning oral formulations as well as sterile injectables, including vials and drug-device delivery systems, which are increasingly critical as peptide programs move rapidly from development to commercial scale.Together, this integrated approach allows us to support customers across the full lifecycle, from peptide intermediates and APIs through to finished dosage forms. In a market defined by speed, scale, and supply assurance, this breadth of capability positions LMS to emerge as one of the leading global players in peptide CDMO services.As the industry convenes at DCAT Week, what is LMS bringing to the table this year?This year is about laying the foundations for LMS’s next phase of growth, particularly in complex and high value modalities. Strategically, our focus is on building the capabilities required to support emerging oncology and peptide adjacent platforms, while preparing for commercial scale-up over the next 18-24 months.On the technology side, LMS already has strong R&D capabilities across peptides, payloads and linkers, bioconjugation, and high potent compounds. These capabilities allow us to engage with customers early in development, solve complex chemistry challenges, and support rapid transition from discovery into development programs. Building on this base, we are progressing plans to establish commercial-scale GMP capacities in payload-linker synthesis and bioconjugation, including the development of a dedicated GMP facility in Vizag. This is a critical step for us as more antibody drug conjugates and related platforms move toward late-stage development and commercialization.Equally important is how we engage with customers. Alongside traditional CDMO models, we are increasingly offering alternative business models such as dedicated facilities, long-term capacity commitments, and guaranteed supply arrangements designed to address customers’ growing concerns around security, scalability, and speed to market. Overall, the year ahead is about execution including strengthening our R&D engine, advancing commercial-scale infrastructure, and deepening customer partnerships so that LMS is well positioned to support complex programs as they move into clinical and commercial reality.LMS has articulated its ambition to emerge as a trusted global CDMO partner with next-generation manufacturing capabilities and scientific agility. How would you assess your progress toward that goal?Trusted partnerships are earned over time, and I am clear-eyed about that. What I can say with confidence is that the strategic choices we have made over the past year have been the right ones, and the investment portfolio we have assembled aligns with direction the industry is heading.The development of our integrated CDMO block at Dabhasa, the scaling of peptide building blocks capabilities, the Vizag HPAPI facility, the PolyPeptide alliance, these reflect a coherent long-term strategy. What continues to occupy my attention most is execution. Infrastructure sets the stage, but it is our science, our quality systems, and our people that customers will ultimately judge us by. That work is ongoing, and it is where I spend most of my time.Could you update us on LMS’ green manufacturing initiatives? How is sustainability being integrated into your operations and facilities?Sustainability has shifted from a compliance requirement to a genuine competitive dimension, and I think that shift is permanent. Customers, investors, and regulators are asking harder questions, and organizations treating it just as a reporting exercise will find themselves at a disadvantage.Our approach remains grounded in the belief that durable environmental improvement comes from process intelligence. When you optimize synthesis routes for atom economy, reduce solvent intensity, and engineer waste out at the design stage, you improve sustainability and manufacturing economics simultaneously. These are not competing priorities. We are embedding green chemistry principles across our development workflows and investing in solvent recovery and waste management infrastructure. Our parent organization Lupin Limited was recently recognized among the top 1% of companies worldwide in the S&P Global Corporate Sustainability Assessment (CSA) attaining an overall score of 91 out of 100 establishing itself as the leading pharmaceutical company globally, and the leader across all sectors in India, surpassing both Indian and international peers which underscores our commitment.

    Impressions: 783

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-re-investing-in-next-gen-cdmo-peptide-building-blocks-infrastructure-to-support-the-evolving-demands-of-complex-therapies

    PharmaCompass
    24 Mar 2026
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaSpecialist in Narcotics and PsychotropicsSpecialist in Narcotics and Psychotropics

    Specialist in Narcotics and Psychotropics
    Specialist in Narcotics and Psychotropics

    reelSpecialist in Narcotics and Psychotropics

    This PharmaReel highlights Rusan Pharma’s 30+ years of expertise in addiction treatment and pain management, specializing in narcotics and psychotropics. Its capabilities span APIs, intermediates, and formulations, supported by backward-integrated manufacturing and GMP-approved facilities certified by USFDA, ANVISA, EMA, PMDA, TGA, and Health Canada.

    Impressions: 1073

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    The market for pharmaceutical excipients — or inactive substances used in the production of drugs —  continued to witness significant transformation in the first quarter (Q1) of 2026. The rise of biologics, increasing demand for personalized medicine, and innovations in drug delivery systems are driving demand for a wider range of functional excipients. As a result, the pharmaceutical excipients market is estimated to grow at a compound annual growth rate (CAGR) of 5.75 percent, to exceed US$ 15.43 billion by 2034. Its size was estimated at US$ 9.31 billion in 2025. The North American market for excipients was estimated at US$ 3.1 billion in 2024 and is estimated to increase to US$ 5.66 billion by 2034. In comparison, the European market for pharmaceutical excipients was estimated at US$ 2.35 billion in 2024 and is predicted to reach around US$ 3.95 billion by 2034, while the Asia Pacific market stood at US$ 1.94 billion in 2024 and is projected to grow to US$ 3.65 billion by 2034.The sector remains highly competitive and fragmented. Major excipient providers include BASF, Roquette, Gangwal Healthcare, Croda International, DuPont, Seqens, SPI Pharma, Evonik, PMC Isochem, Pfanstiehl, Colorcon, Kewpie Corporation, ICE Pharma, Nanjing Well Pharmaceutical, Merck KGaA-owned MilliporeSigma, Minakem, Ashland Global and Nippon Fine Chemical.Clariant sets up its first PEG excipients facility in US; Croda opens greenfield facility in India Swiss specialty chemical company Clariant is expanding its Clear Lake (Texas) site to include GMP-compliant manufacturing of pharmaceutical-grade polyethylene glycol (PEG) excipients. This will improve availability and reliability for North American customers, with extended reach to Latin America. The multi-phase expansion addresses critical industry priorities around supply chain security, continuity, and responsiveness while demonstrating Clariant’s long-term strategic commitment to the US pharmaceutical market. This is the first Clariant facility in the US to manufacture PEG excipients for oral and topical applications.British specialty chemicals company Croda International has inaugurated a greenfield manufacturing facility in Dahej, India, that strengthens its ability to serve fast-growing markets in Asia. The new site represents a significant investment in India and will enhance Croda’s supply capabilities, improve responsiveness to customer demand, and support future growth in high-value sectors. Located in Gujarat, the facility benefits from strong logistics connectivity and is designed to serve both domestic customers and select export markets. It will support demand across Croda’s consumer care, life sciences, and industrial specialties sectors. Following the acquisition of IFF Pharma Solutions in 2025, French excipient company Roquette has introduced an expanded cosmetics portfolio under the Roquette Beauté brand. This portfolio integrates IFF Pharma Solutions’ ingredients — Methocel, Avicel, Aquacoat, Ethocel, and Polyox — with Roquette’s legacy range, while its core portfolio continues to include widely used pharmaceutical excipients. View Our Dashboard on Major Excipient Companies in 2026 (Free Excel Available)SPI Pharma-Anek Prayog, Ingredion-Univar ink distribution deals; DFE Pharma, Gericke launch CM platformIn February, US-based pharmaceutical excipient and ingredients company SPI Pharma announced a global distribution partnership with Indian pharmaceutical excipient manufacturer Anek Prayog. Under this agreement, SPI will exclusively sell, promote, and distribute Lubripharm Pro SSF, a next-generation sodium stearyl fumarate lubricant manufactured by Anek Prayog.The Ingredients + Specialties division of Univar Solutions was appointed as a distributor for Ingredion Pharma Solutions. The agreement includes distribution of Ingredion’s global pharmaceuticals portfolio and positions Univar as the exclusive distributor of pharmaceutical starches in the US and Canada. The partnership expands its pharmaceutical and nutraceutical excipient offerings, including binders, fillers, superdisintegrants, lubricants, and gelatin alternatives.German excipient solutions company DFE Pharma has launched a continuous manufacturing (CM) platform in collaboration with Switzerland-based Gericke Group to support formulation development, optimization, and lifecycle management. The platform integrates CM-ready excipients, a flexible evaluation environment, and multidisciplinary expertise to enable data-driven decisions from early development to commercial manufacturing.As part of this initiative, DFE Pharma has established CM capabilities at its C2F Center of Excellence in Hyderabad, featuring a Gericke Formulation Skid (GFS) in a non-GMP setup. This modular system enables rapid testing, process optimization, and practical assessment of continuous feeding and blending without impacting existing GMP operations, while supporting alignment with ICH Q13 (an international guideline on CM for drug substances and products).Gangwal Healthcare operates EXCiPACT-certified GMP facilities and offers a broad range of functional excipients, including co-processed blends like ProBlend, Starlose, Tyloxapole, and Microlose. Its excipients, including Solvostar (sodium starch glycolate) and LubMag-W (Magnesium Stearate, Sodium Lauryl Sulfate), support enhanced tablet disintegration and drug release. The company also provides taste-masking agents such as SucreX (sucralose) and CutCal (neotame), supporting the development of patient-friendly oral dosage forms. View Our Dashboard on Major Excipient Companies in 2026 (Free Excel Available)India harmonizes 22 excipient monographs; EMA updates TE guidelines for inhalation products Regulators are increasingly tightening requirements around excipients, as they are no longer treated as passive ingredients. They are being recognized as critical to product performance and therapeutic equivalence.India has introduced the Indian Pharmacopoeia 2026 with updated and harmonized standards for pharmaceutical ingredients, including 22 excipient monographs. These revisions align Indian standards more closely with global pharmacopoeias. For excipient manufacturers and drug formulators, this means stricter compliance expectations. In August, India had notified an amendment to the Drugs Rules, 1945 to mandate inclusion of qualitative details of excipients in drug labels through barcodes or QR codes from 2026.The European Medicines Agency (EMA) has issued updated guidelines on the pharmaceutical quality of inhalation and nasal medicines, as well as on demonstrating therapeutic equivalence (TE) of orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease. These guidelines require manufacturers to provide detailed information on the active substance, finished product composition, pharmaceutical development studies, and the control of excipients and other formulation components. Similar pharmaceutical quality requirements apply to nasal products under the pharmaceutical quality guideline.Excipients are becoming increasingly linked to manufacturing technologies. For instance, the US Food and Drug Administration (FDA) finalized its Advanced Manufacturing Technologies (AMT) Designation Program in 2024. This is expected to increase the need for excipients compatible with such technologies. View Our Dashboard on Major Excipient Companies in 2026 (Free Excel Available)Our view While the market for excipients is growing at a healthy pace, the ongoing conflict in the Middle East is disrupting pharmaceutical supply chains, with impacts now extending beyond APIs to critical excipients and packaging materials. Surging crude oil prices are driving up the cost of excipients, with key inputs like chloroform witnessing sharp price increases. In addition, disruptions in logistics are forcing drugmakers to reroute shipments through longer and more expensive routes due to closure of airports and certain sea routes. These developments will have a cascading effect on the pharmaceutical industry and its supply chain in the coming months.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 323

    https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-clariant-sets-up-its-first-peg-excipients-facility-in-us-india-harmonizes-22-excipient-monographs

    #PharmaFlow by PHARMACOMPASS
    26 Mar 2026
    Share Share

    NEWS #PharmaBuzz

    [Sponsored by another company]read-more
    read-more
    Medisca Settles with FlackTek, strengthens MAZ® Mixer Patent
    Medisca Settles with FlackTek, strengthens MAZ® Mixer Patent

    10 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250610770292/en/Medisca-Secures-Settlement-With-FlackTek-Reinforcing-Patent-Strength-of-MAZ-Mixer

    BUSINESSWIRE
    10 Jun 2025
    Share Share
    Medisca Statement on Settlement With Department of Justice
    Medisca Statement on Settlement With Department of Justice

    01 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241101949692/en

    BUSINESSWIRE
    01 Nov 2024
    Share Share
    Enforcement Report - Week of July 10, 2024
    Enforcement Report - Week of July 10, 2024

    10 Jul 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-10-2024-51523.pdf

    FDA
    10 Jul 2024
    Share Share
    Medisca Opens New Facility to Meet Personalized Medicine Demand
    Medisca Opens New Facility to Meet Personalized Medicine Demand

    27 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240627482773/en

    BUSINESSWIRE
    27 Jun 2024
    Share Share
    Medisca Appoints Sanjay D. Goorachurn As CEO
    Medisca Appoints Sanjay D. Goorachurn As CEO

    16 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240416663563/en

    BUSINESSWIRE
    16 Apr 2024
    Share Share
    Medisca Opens MAZ® Lab in Arizona: An Innovation and Customer Resource Center
    Medisca Opens MAZ® Lab in Arizona: An Innovation and Customer Resource Center

    26 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240326567439/en

    BUSINESSWIRE
    26 Mar 2024
    Share Share
    Contact Medisca and get a quotation

    Medisca is a supplier offers 251 products (APIs, Excipients or Intermediates).

    Find a price of Acetazolamide bulk offered by Medisca

    Find a price of Acyclovir bulk offered by Medisca

    Find a price of Alpha Lipoic Acid bulk offered by Medisca

    Find a price of Alprostadil bulk offered by Medisca

    Find a price of Altrenogest bulk offered by Medisca

    Find a price of Amantadine Hydrochloride bulk offered by Medisca

    Find a price of Amitriptyline Hydrochloride bulk offered by Medisca

    Find a price of Amlodipine Besylate bulk offered by Medisca

    Find a price of Amphotericin B bulk offered by Medisca

    Find a price of Anastrozole bulk offered by Medisca

    Find a price of Apomorphine Hydrochloride bulk offered by Medisca

    Find a price of Aspirin bulk offered by Medisca

    Find a price of Atenolol bulk offered by Medisca

    Find a price of Atropine Sulfate bulk offered by Medisca

    Find a price of Azathioprine bulk offered by Medisca

    Find a price of Azelaic Acid bulk offered by Medisca

    Find a price of Azithromycin Dihydrate bulk offered by Medisca

    Find a price of Bacitracin Zinc bulk offered by Medisca

    Find a price of Baclofen bulk offered by Medisca

    Find a price of Beclomethasone Dipropionate bulk offered by Medisca

    Find a price of Benzocaine bulk offered by Medisca

    Find a price of Beta Nicotinamide Adenine Dinucleotide bulk offered by Medisca

    Find a price of Betahistine Dihydrochloride bulk offered by Medisca

    Find a price of Betamethasone Dipropionate bulk offered by Medisca

    Find a price of Betamethasone Sodium Phosphate bulk offered by Medisca

    Find a price of Betamethasone Valerate bulk offered by Medisca

    Find a price of Bimatoprost bulk offered by Medisca

    Find a price of Biotin bulk offered by Medisca

    Find a price of Bisoprolol Fumarate bulk offered by Medisca

    Find a price of Budesonide bulk offered by Medisca

    Find a price of Bupivacaine Hydrochloride bulk offered by Medisca

    Find a price of Buprenorphine bulk offered by Medisca

    Find a price of Bupropion Hydrochloride bulk offered by Medisca

    Find a price of Butalbital bulk offered by Medisca

    Find a price of Butorphanol Tartrate bulk offered by Medisca

    Find a price of Caffeine bulk offered by Medisca

    Find a price of Carbamazepine bulk offered by Medisca

    Find a price of Carbidopa bulk offered by Medisca

    Find a price of Chloral Hydrate bulk offered by Medisca

    Find a price of Chloramphenicol Succinate Acid bulk offered by Medisca

    Find a price of Chlorothiazide bulk offered by Medisca

    Find a price of Chlorpromazine Hydrochloride bulk offered by Medisca

    Find a price of Cholestyramine bulk offered by Medisca

    Find a price of Ciclopirox Olamine bulk offered by Medisca

    Find a price of Cimetidine bulk offered by Medisca

    Find a price of Ciprofloxacin Hydrochloride bulk offered by Medisca

    Find a price of Clindamycin Hydrochloride bulk offered by Medisca

    Find a price of Clindamycin Phosphate bulk offered by Medisca

    Find a price of Clioquinol bulk offered by Medisca

    Find a price of Clobetasol Propionate bulk offered by Medisca

    Find a price of Clomiphene Citrate bulk offered by Medisca

    Find a price of Clomipramine Hydrochloride bulk offered by Medisca

    Find a price of Clonidine bulk offered by Medisca

    Find a price of Clotrimazole bulk offered by Medisca

    Find a price of Cocaine Hydrochloride bulk offered by Medisca

    Find a price of Codeine Phosphate bulk offered by Medisca

    Find a price of Corticotropin bulk offered by Medisca

    Find a price of Cyclobenzaprine bulk offered by Medisca

    Find a price of Cyclopentolate Hydrochloride bulk offered by Medisca

    Find a price of Cyclophosphamide bulk offered by Medisca

    Find a price of Cyclosporine bulk offered by Medisca

    Find a price of Cyproheptadine Hydrochloride bulk offered by Medisca

    Find a price of Danazol bulk offered by Medisca

    Find a price of Dehydroepiandrosterone bulk offered by Medisca

    Find a price of Desonide bulk offered by Medisca

    Find a price of Dexamethasone bulk offered by Medisca

    Find a price of Dexamethasone Sodium Phosphate bulk offered by Medisca

    Find a price of Dextromethorphan Hydrobromide bulk offered by Medisca

    Find a price of Diazepam bulk offered by Medisca

    Find a price of Diazoxide bulk offered by Medisca

    Find a price of Diclofenac Sodium bulk offered by Medisca

    Find a price of Diethylpropion Hydrochloride bulk offered by Medisca

    Find a price of Dihydroergotamine Mesylate bulk offered by Medisca

    Find a price of Dihydroergotoxine Mesylate bulk offered by Medisca

    Find a price of Diltiazem Hydrochloride bulk offered by Medisca

    Find a price of Diphenhydramine Hydrochloride bulk offered by Medisca

    Find a price of Doxepin Hydrochloride bulk offered by Medisca

    Find a price of Doxycycline Hyclate bulk offered by Medisca

    Find a price of Dutasteride bulk offered by Medisca

    Find a price of Enalapril Maleate bulk offered by Medisca

    Find a price of Enrofloxacin bulk offered by Medisca

    Find a price of Ergotamine Tartrate bulk offered by Medisca

    Find a price of Erythromycin bulk offered by Medisca

    Find a price of Estriol bulk offered by Medisca

    Find a price of Famotidine bulk offered by Medisca

    Find a price of Fampridine bulk offered by Medisca

    Find a price of Fenbendazole bulk offered by Medisca

    Find a price of Fentanyl Citrate bulk offered by Medisca

    Find a price of Finasteride bulk offered by Medisca

    Find a price of Fluconazole bulk offered by Medisca

    Find a price of Fludrocortisone Acetate bulk offered by Medisca

    Find a price of Flunixin Meglumine bulk offered by Medisca

    Find a price of Fluocinolone Acetonide bulk offered by Medisca

    Find a price of Fluorouracil bulk offered by Medisca

    Find a price of Fluoxetine Hydrochloride bulk offered by Medisca

    Find a price of Flurbiprofen bulk offered by Medisca

    Find a price of Fluticasone Propionate bulk offered by Medisca

    Find a price of Formoterol Fumarate bulk offered by Medisca

    Find a price of Furosemide bulk offered by Medisca

    Find a price of Gabapentin bulk offered by Medisca

    Find a price of Gentamicin Sulfate bulk offered by Medisca

    Find a price of Glipizide bulk offered by Medisca

    Find a price of Glycopyrronium Bromide bulk offered by Medisca

    Find a price of Guaifenesin bulk offered by Medisca

    Find a price of Haloperidol bulk offered by Medisca

    Find a price of Hydrocodone Bitartrate bulk offered by Medisca

    Find a price of Hydrocortisone bulk offered by Medisca

    Find a price of Hydrocortisone Acetate bulk offered by Medisca

    Find a price of Hydromorphone Hydrochloride bulk offered by Medisca

    Find a price of Hydroquinone bulk offered by Medisca

    Find a price of Hydroxyurea bulk offered by Medisca

    Find a price of Hydroxyzine Hydrochloride bulk offered by Medisca

    Find a price of Ibuprofen bulk offered by Medisca

    Find a price of Imipramine Hydrochloride bulk offered by Medisca

    Find a price of Itraconazole bulk offered by Medisca

    Find a price of Ivermectin bulk offered by Medisca

    Find a price of Ketamine Hydrochloride bulk offered by Medisca

    Find a price of Ketoconazole bulk offered by Medisca

    Find a price of Ketoprofen bulk offered by Medisca

    Find a price of Ketorolac Trometamol bulk offered by Medisca

    Find a price of Ketotifen Fumarate bulk offered by Medisca

    Find a price of Lansoprazole bulk offered by Medisca

    Find a price of Levetiracetam bulk offered by Medisca

    Find a price of Levofloxacin bulk offered by Medisca

    Find a price of Levoleucovorin Calcium bulk offered by Medisca

    Find a price of Lidocaine bulk offered by Medisca

    Find a price of Lidocaine Hydrochloride bulk offered by Medisca

    Find a price of Liothyronine Sodium bulk offered by Medisca

    Find a price of Loperamide Hydrochloride bulk offered by Medisca

    Find a price of Loratadine bulk offered by Medisca

    Find a price of Mefenamic Acid bulk offered by Medisca

    Find a price of Melatonin bulk offered by Medisca

    Find a price of Meloxicam bulk offered by Medisca

    Find a price of Metformin bulk offered by Medisca

    Find a price of Methadone Hydrochloride bulk offered by Medisca

    Find a price of Methimazole bulk offered by Medisca

    Find a price of Methocarbamol bulk offered by Medisca

    Find a price of Methylcobalamin bulk offered by Medisca

    Find a price of Methylene Blue bulk offered by Medisca

    Find a price of Methylphenidate Hydrochloride bulk offered by Medisca

    Find a price of Methylprednisolone Acetate bulk offered by Medisca

    Find a price of Metoprolol Tartrate bulk offered by Medisca

    Find a price of Metronidazole bulk offered by Medisca

    Find a price of Miconazole Nitrate bulk offered by Medisca

    Find a price of Minoxidil bulk offered by Medisca

    Find a price of Mirtazapine bulk offered by Medisca

    Find a price of Misoprostol bulk offered by Medisca

    Find a price of Mitomycin bulk offered by Medisca

    Find a price of Mitotane bulk offered by Medisca

    Find a price of Mometasone Furoate bulk offered by Medisca

    Find a price of Morphine Sulfate bulk offered by Medisca

    Find a price of Naloxone Hydrochloride bulk offered by Medisca

    Find a price of Naltrexone Hydrochloride bulk offered by Medisca

    Find a price of Naproxen bulk offered by Medisca

    Find a price of Neomycin Sulfate bulk offered by Medisca

    Find a price of Neostigmine Methylsulfate bulk offered by Medisca

    Find a price of Niacinamide bulk offered by Medisca

    Find a price of Nifedipine bulk offered by Medisca

    Find a price of Norepinephrine Bitartrate bulk offered by Medisca

    Find a price of Nystatin bulk offered by Medisca

    Find a price of Omeprazole bulk offered by Medisca

    Find a price of Ondansetron Hydrochloride bulk offered by Medisca

    Find a price of Orphenadrine bulk offered by Medisca

    Find a price of Oxybutynin Hydrochloride bulk offered by Medisca

    Find a price of Oxycodone Hydrochloride bulk offered by Medisca

    Find a price of Oxytocin bulk offered by Medisca

    Find a price of Papaverine Hydrochloride bulk offered by Medisca

    Find a price of Paracetamol bulk offered by Medisca

    Find a price of Paroxetine Hydrochloride bulk offered by Medisca

    Find a price of Pentosan Polysulfate Sodium bulk offered by Medisca

    Find a price of Pentoxifylline bulk offered by Medisca

    Find a price of Pergolide Mesylate bulk offered by Medisca

    Find a price of Pethidine Hydrochloride bulk offered by Medisca

    Find a price of Phenobarbital bulk offered by Medisca

    Find a price of Phentermine Hydrochloride bulk offered by Medisca

    Find a price of Phenylpropanolamine Hydrochloride bulk offered by Medisca

    Find a price of Phenytoin Sodium bulk offered by Medisca

    Find a price of Pilocarpine Hydrochloride bulk offered by Medisca

    Find a price of Pimobendan bulk offered by Medisca

    Find a price of Piroxicam bulk offered by Medisca

    Find a price of Polymyxin B Sulfate bulk offered by Medisca

    Find a price of Ponazuril bulk offered by Medisca

    Find a price of Potassium Bromide bulk offered by Medisca

    Find a price of Pramoxine Hydrochloride bulk offered by Medisca

    Find a price of Prasterone bulk offered by Medisca

    Find a price of Praziquantel bulk offered by Medisca

    Find a price of Prednisolone Acetate bulk offered by Medisca

    Find a price of Prednisolone Sodium Phosphate bulk offered by Medisca

    Find a price of Prednisone bulk offered by Medisca

    Find a price of Pregnenolone bulk offered by Medisca

    Find a price of Prilocaine Hydrochloride bulk offered by Medisca

    Find a price of Probenecid bulk offered by Medisca

    Find a price of Prochlorperazine Maleate bulk offered by Medisca

    Find a price of Progesterone bulk offered by Medisca

    Find a price of Promethazine Hydrochloride bulk offered by Medisca

    Find a price of Pyrantel Pamoate bulk offered by Medisca

    Find a price of Ranitidine Hydrochloride bulk offered by Medisca

    Find a price of Rifampicin bulk offered by Medisca

    Find a price of Salicylic Acid bulk offered by Medisca

    Find a price of Selegiline Hydrochloride bulk offered by Medisca

    Find a price of Sertraline Hydrochloride bulk offered by Medisca

    Find a price of Sildenafil Citrate bulk offered by Medisca

    Find a price of Sodium Cromoglicate bulk offered by Medisca

    Find a price of Sodium Hyaluronate bulk offered by Medisca

    Find a price of Sodium Phenylbutyrate bulk offered by Medisca

    Find a price of Sodium Valproate bulk offered by Medisca

    Find a price of Spironolactone bulk offered by Medisca

    Find a price of Succimer bulk offered by Medisca

    Find a price of Succinylcholine Chloride bulk offered by Medisca

    Find a price of Sucralfate bulk offered by Medisca

    Find a price of Sufentanil Citrate bulk offered by Medisca

    Find a price of Sulfacetamide Sodium bulk offered by Medisca

    Find a price of Sulfadiazine bulk offered by Medisca

    Find a price of Sulfamethoxazole bulk offered by Medisca

    Find a price of Sulfasalazine bulk offered by Medisca

    Find a price of Tacrolimus bulk offered by Medisca

    Find a price of Tadalafil bulk offered by Medisca

    Find a price of Terbinafine Hydrochloride bulk offered by Medisca

    Find a price of Testosterone bulk offered by Medisca

    Find a price of Testosterone Cypionate bulk offered by Medisca

    Find a price of Testosterone Propionate bulk offered by Medisca

    Find a price of Tetracaine bulk offered by Medisca

    Find a price of Tetracaine Hydrochloride bulk offered by Medisca

    Find a price of Tetracycline Hydrochloride bulk offered by Medisca

    Find a price of Theophylline bulk offered by Medisca

    Find a price of Thiamine Hydrochloride bulk offered by Medisca

    Find a price of Thyroid bulk offered by Medisca

    Find a price of Thyroxine bulk offered by Medisca

    Find a price of Tinidazole bulk offered by Medisca

    Find a price of Tizanidine Hydrochloride bulk offered by Medisca

    Find a price of Tobramycin Sulfate bulk offered by Medisca

    Find a price of Toltrazuril bulk offered by Medisca

    Find a price of Topiramate bulk offered by Medisca

    Find a price of Tramadol Hydrochloride bulk offered by Medisca

    Find a price of Tranexamic Acid bulk offered by Medisca

    Find a price of Trazodone Hydrochloride bulk offered by Medisca

    Find a price of Tretinoin bulk offered by Medisca

    Find a price of Triamcinolone Acetonide bulk offered by Medisca

    Find a price of Trichlormethiazide bulk offered by Medisca

    Find a price of Trilostane bulk offered by Medisca

    Find a price of Trimethoprim bulk offered by Medisca

    Find a price of Tropicamide bulk offered by Medisca

    Find a price of Tylosin Tartrate bulk offered by Medisca

    Find a price of Unithiol bulk offered by Medisca

    Find a price of Ursodeoxycholic Acid bulk offered by Medisca

    Find a price of Valacyclovir Hydrochloride bulk offered by Medisca

    Find a price of Vancomycin Hydrochloride bulk offered by Medisca

    Find a price of Verapamil Hydrochloride bulk offered by Medisca

    Find a price of Vitamin B12 bulk offered by Medisca

    Find a price of Vitamin D bulk offered by Medisca

    Find a price of Zonisamide bulk offered by Medisca

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.